Basit öğe kaydını göster

dc.contributor.authorTopal, Yaşar
dc.contributor.authorTopal, Hatice
dc.contributor.authorCeyhan, Mustafa Nuri
dc.contributor.authorAzık, Fatih
dc.contributor.authorÇapanoğlu, Murat
dc.contributor.authorKocabaş, Can Naci
dc.date.accessioned2020-11-20T15:07:18Z
dc.date.available2020-11-20T15:07:18Z
dc.date.issued2015
dc.identifier.issn0363-0269
dc.identifier.issn1532-432X
dc.identifier.urihttps://doi.org/10.3109/03630269.2015.1046185
dc.identifier.urihttps://hdl.handle.net/20.500.12809/3228
dc.descriptionWOS: 000361322400006en_US
dc.descriptionPubMed ID: 26120034en_US
dc.description.abstractThalassemia is an autosomal recessive inherited blood disorder. It is prevalent in Mediterranean countries such as Sardinia, Greece, Cyprus, Turkey, Lebanon and also Southeast Asia. Our aim was to investigate the carrier prevalence of thalassemia and other hemoglobinopathies in adolescents who live in Mug. la Province, Turkey. We analyzed retrospectively the surveys conducted at primary schools between 1997 and 2013. Complete blood count (CBC) and high performance liquid chromatography (HPLC) were used to screen for thalassemia and hemoglobinopathies. Patients were diagnosed as having thalassemia trait if the mean corpuscular volume (MCV) was <= 80.0 fL, mean corpuscular hemoglobin (Hb) was <= 27.0 pg and Hb A(2) levels were >= 3.5%. A total of 164 814 students were analyzed. The median age of the students was 13.5 years (minimum 13.0, maximum 14.0). The total number of students with abnormal HPLC results was 5861 (3.8%). There was a significant decrease in the newborn of new thalassemia patients found with screening programs for hemoglobinopathies in Mug. la Province from 1997 to 2013. The number of students with abnormal HPLC results for thalassemia, sickle cell disease and other Hb traits were 3.2, 0.15 and 0.4%, respectively. It is important to recognize that including Hb, MCV, red blood cell (RBC) count and HPLC tests for carrier screening are necessary to find hemoglobinopathies. Our study supported that the number of new patients significantly decreased using these screening programs from 1997 to 2013.en_US
dc.item-language.isoengen_US
dc.publisherTaylor & Francis Ltden_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFrequencyen_US
dc.subjectHemoglobinopathiesen_US
dc.subjectScreening Program(S)en_US
dc.subjectThalassemiaen_US
dc.titleThe Prevalence of Hemoglobinopathies in Young Adolescents in the Province of Mugla in Turkey: Results of a Screening Programen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorTopal, Yaşar
dc.contributor.institutionauthorTopal, Hatice
dc.contributor.institutionauthorCeyhan, Mustafa Nuri
dc.contributor.institutionauthorAzık, Fatih
dc.contributor.institutionauthorKocabaş, Can Naci
dc.identifier.doi10.3109/03630269.2015.1046185
dc.identifier.volume39en_US
dc.identifier.issue4en_US
dc.identifier.startpage247en_US
dc.identifier.endpage250en_US
dc.relation.journalHemoglobinen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster